당사는 귀하가 당사 사이트를 어떻게 이용하는지 이해하고 귀하의 사용 편리성을 향상시키기 위해 쿠키를 사용합니다. 여기에는 개인화 콘텐츠 및 광고가 포함됩니다. 당사 사이트를 계속 이용하는 것은 당사의 쿠키사용 정책에 동의하는 것으로 간주됩니다. Cookies, Privacy Policy Term of use.
Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
0/10806
4,604 views • August 4, 2022

First Senate Hearing on Gain of Function Research Since Start of Pandemic

NTD News
NTD News
Sens. Rand Paul (R-Ky.) and Maggie Hassan (D-N.H.) are leading the first congressional hearing on gain-of-function research as part of his ongoing efforts to investigate the origins of the COVID-19 pandemic. The hearing is scheduled at 2:30 p.m. ET on Aug. 3. Access the livestream on this page. The hearing comes amid intensifying Republican scrutiny on whether a leak from the Wuhan Institute of Virology (WIV) caused the pandemic, as well as possible U.S. funding ties to the gain-of-function research at the facility. Gain-of-function involves enhancing a virus to make it more potent or transmissible. Titled “Revisiting Gain-of-Function Research: What the Pandemic Taught Us and Where Do We Go From Here,” the hearing will be held by the Senate Homeland Security & Governmental Affairs Committee’s Subcommittee on Emerging Threats and Spending Oversight, of which Hassan and Paul are chair and ranking member respectively. Member Statements Chair Margaret Wood Hassan (D-N.H.) Ranking Member Rand Paul (R-Ky.) Witnesses Richard H. Ebright, PhD Laboratory Director, Waksman Institute of Microbiology Rutgers University Steven Quay, MD, PhD Chief Executive Officer Atossa Therapeutics, Inc. Kevin M. Esvelt, PhD Assistant Professor of Media Arts and Sciences MIT Media Lab
Show All
Comment 0